Home › Colorectal Cancer › Arizona › Scottsdale
Pag-aaral pangklinika para sa Colorectal Cancer sa Scottsdale, AZ
16 pag-aaral para sa Colorectal Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Scottsdale (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Nagre-recruitPhase 1
- Honor Health Research Institute, Scottsdale
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Mayo Clinic, Scottsdale
- Ironwood Cancer & Research Centers, Scottsdale
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Nagre-recruitPhase 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
Nagre-recruitPhase 1
- HonorHealth, Scottsdale
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Nagre-recruitPhase 1/2
- HonorHealth Research Institute, Scottsdale
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Nagre-recruitPhase 2
- Research Site, Scottsdale
Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients
Nagre-recruitObservasyonal na pag-aaral
- Mayo Clinic in Arizona, Scottsdale
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Honor Health, Scottsdale
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Mayo Clinic (Arizona), Scottsdale
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
Nagre-recruitPhase 3
- Mayo Clinic, Scottsdale
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Nagre-recruitPhase 1
- Mayo Clinic, Scottsdale
Addressing Disparities in Colorectal Cancer Screening in Black and Underserved Phoenix Communities
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Mayo Clinic in Arizona, Scottsdale
Safety and Efficacy of Tegavivint in Patients With Metastatic Colorectal Carcinoma
Nagre-recruitPhase 1/2
- Clinical Trials Nurse Navigator, Scottsdale
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Nagre-recruitPhase 4
- Scottsdale Medical Imaging, LLC, Scottsdale
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Nagre-recruitPhase 1/2
- Mayo Clinic in Arizona, Scottsdale
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1
- HonorHealth Research Institute, Scottsdale
Pag-aaral para sa Colorectal Cancer sa ibang lungsod
- Houston, TX102 pag-aaral
- New York City, NY78 pag-aaral
- Nashville, TN69 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA59 pag-aaral
- Arlington, VA52 pag-aaral
- St. Louis, MO50 pag-aaral
- San Antonio, TX46 pag-aaral
- Philadelphia, PA44 pag-aaral
- Grand Rapids, MI40 pag-aaral
- Baldwin Park, CA37 pag-aaral
- Chicago, IL34 pag-aaral
Iba pang pag-aaral sa Scottsdale
- Kanser sa Suso18 pag-aaral
- Kanser (lahat ng uri)18 pag-aaral
- Metastatic Cancer17 pag-aaral
- Kanser sa Prostate17 pag-aaral
- Non-Small Cell Lung Cancer15 pag-aaral
- Kanser sa Pancreas13 pag-aaral
- Melanoma10 pag-aaral
- Ulcerative Colitis8 pag-aaral
- Kanser sa Baga8 pag-aaral
- Kanser sa Atay (Hepatocellular Carcinoma)7 pag-aaral
- Sakit ni Alzheimer7 pag-aaral
- Triple-Negative Breast Cancer7 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.